257 related articles for article (PubMed ID: 17655675)
21. Obstetric management of a patient with Andersen-Tawil syndrome: A case report.
Inagaki M; Tatsumi T; Yomogita H; Hirose A; Kubo T; Sekiguchi M; Miyasaka N
J Obstet Gynaecol Res; 2021 Jan; 47(1):446-451. PubMed ID: 33205612
[TBL] [Abstract][Full Text] [Related]
22. Flecainide treats a novel
Van Ert HA; McCune EC; Orland KM; Maginot KR; Von Bergen NH; January CT; Eckhardt LL
HeartRhythm Case Rep; 2017 Feb; 3(2):151-154. PubMed ID: 28491792
[No Abstract] [Full Text] [Related]
23. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC
Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868
[TBL] [Abstract][Full Text] [Related]
24. [Effective dose of flecainide for arrhythmia in children].
Sumitomo N; Ushinohama H; Hara M; Otuka M; Harada K; Okuni M
Kokyu To Junkan; 1993 Nov; 41(11):1079-82. PubMed ID: 8256048
[TBL] [Abstract][Full Text] [Related]
25. Andersen-Tawil syndrome associated with aborted sudden cardiac death: atrial pacing was effective for ventricular arrhythmias.
Kuramoto Y; Furukawa Y; Yamada T; Okuyama Y; Fukunami M
Am J Med Sci; 2012 Sep; 344(3):248-50. PubMed ID: 22739561
[TBL] [Abstract][Full Text] [Related]
26. [Andersen-Tawil syndrome. Efficacy of class IC drugs].
Makarov LM; Komoliatova VN; Kolosov VO; Fedina NN; Solokhin IuA
Kardiologiia; 2013; 53(1):91-6. PubMed ID: 23548357
[TBL] [Abstract][Full Text] [Related]
27. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
[TBL] [Abstract][Full Text] [Related]
28. Andersen-Tawil syndrome: management challenges during pregnancy, labor, and delivery.
Subbiah RN; Gula LJ; Skanes AC; Krahn AD
J Cardiovasc Electrophysiol; 2008 Sep; 19(9):987-9. PubMed ID: 18554214
[TBL] [Abstract][Full Text] [Related]
29. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
[TBL] [Abstract][Full Text] [Related]
30. Type II bidirectional ventricular tachycardia in a patient with myocardial infarction.
Sonmez O; Gul EE; Duman C; Düzenli MA; Tokaç M; Cooper J
J Electrocardiol; 2009; 42(6):631-2. PubMed ID: 19682706
[TBL] [Abstract][Full Text] [Related]
31. Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome.
Sumitomo N; Shimizu W; Taniguchi K; Hiraoka M
Heart Rhythm; 2008 Mar; 5(3):498-9. PubMed ID: 18313615
[No Abstract] [Full Text] [Related]
32. [Tachycardia-induced cardiomyopathy, unusual and reversible cause of left ventricular dysfunction: report of 9 cases].
Quiniou G; Chevalier JM; Barbou F; Bire F; Clémenty J
Ann Cardiol Angeiol (Paris); 2000 Aug; 49(5):301-8. PubMed ID: 12555514
[TBL] [Abstract][Full Text] [Related]
33. T75M-KCNJ2 mutation causing Andersen-Tawil syndrome enhances inward rectification by changing Mg2+ sensitivity.
Tani Y; Miura D; Kurokawa J; Nakamura K; Ouchida M; Shimizu K; Ohe T; Furukawa T
J Mol Cell Cardiol; 2007 Aug; 43(2):187-96. PubMed ID: 17582433
[TBL] [Abstract][Full Text] [Related]
34. Combined inhibition of Na⁺ and Ca²⁺ channels: a novel paradigm for the treatment of incessant ventricular arrhythmias in Andersen-Tawil syndrome.
Janson CM; Poelzing S; Shah MJ
Heart Rhythm; 2014 Feb; 11(2):318-20. PubMed ID: 24211314
[No Abstract] [Full Text] [Related]
35. Bidirectional Ventricular Tachycardia and Prominent U Waves: Look at Fingers and Muscles and Use Flecainide.
Oreto L; Briuglia S; Capra AP; Ruiz VG; Di Pino A
J Pediatr Pharmacol Ther; 2023; 28(7):662-666. PubMed ID: 38025154
[TBL] [Abstract][Full Text] [Related]
36. [The action of intravenous flecainide in experimental ventricular arrhythmias].
de Micheli A; Medrano GA; Casanova JM
Arch Inst Cardiol Mex; 1995; 65(5):403-12. PubMed ID: 8678696
[TBL] [Abstract][Full Text] [Related]
37. Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy.
Ermakov S; Hoffmayer KS; Gerstenfeld EP; Scheinman MM
Pacing Clin Electrophysiol; 2014 Jan; 37(1):90-4. PubMed ID: 24102153
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of tachycardia-induced cardiomyopathy with LVAD in a 12-year-old boy.
Tatewaki H; Masuda M; Nishida T; Kaji Y; Ushinohama H; Morita S; Yasui H
Ann Thorac Surg; 2005 Aug; 80(2):e5-7. PubMed ID: 16039171
[TBL] [Abstract][Full Text] [Related]
39. Fetal ventricular tachycardia secondary to long QT syndrome treated with maternal intravenous magnesium: case report and review of the literature.
Simpson JM; Maxwell D; Rosenthal E; Gill H
Ultrasound Obstet Gynecol; 2009 Oct; 34(4):475-80. PubMed ID: 19731233
[TBL] [Abstract][Full Text] [Related]
40. An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.
Oguayo KN; Oyetayo OO; Costa SM; Mixon TA
Pharmacotherapy; 2014 May; 34(5):e30-3. PubMed ID: 24510469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
